Sonendo, Inc. on Path to Breakeven in the Second Half of 2026

Core Insights - Sonendo, Inc. is on track to achieve breakeven in the second half of 2026, supported by operational improvements and strategic collaborations [1][4]. Financial Performance - The company reported a significant reduction in free cash flow burn to $10.9 million in 2025 from $24.8 million in 2024 [4]. - Loss from operations decreased to $13.5 million in 2025 from $29.4 million in 2024, while adjusted EBITDA loss improved to $10.4 million from $23.0 million in the same period [4]. - Gross margin increased to 41.9% for the full year of 2025, up 460 basis points compared to 2024 [4]. - Total revenue for 2025 was $28.6 million, with approximately 82% ($23.4 million) coming from recurring sales of procedure-related consumables and services [4]. Strategic Developments - On November 17, 2025, Sonendo entered a strategic collaboration with a European-based dental company, gaining exclusive rights to sell high-quality products in North America [1]. - The first product launched under this collaboration is FlowLogic™ endodontic files, expected to compete effectively in the market while being offered at a significant discount to GentleWave customers [2]. Product and Market Position - The GentleWave System is designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth, preserving tooth structure and improving clinical outcomes compared to conventional methods [5]. - Over 1.9 million patients have been treated with the GentleWave System, demonstrating its value to endodontists and patients [3].